Hepotacellular Carcinoma

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Hepotacellular Carcinoma trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

RecruitingPhase 1/2

NCT07282184

Multimodal Deep Learning for Postoperative Liver Cancer Risk Stratification and Intervention

This study is for patients with early-stage liver cancer who are planning to have surgery. The goal of this research is to see if a personalized treatment plan,…

China144 participantsStarted 2025-10-26

Treatment: Neoadjuvant HAIC + Lenvatinib + PD-1 Inhibitor, Curative Liver Resection

RecruitingNot Applicable

NCT07147335

The Role of Serum AKR1B10 in Early Warning of Hepatocellular Carcinoma in Cirrhosis Patients

Hepatocellular carcinoma (HCC) is a globally prevalent malignancy. In its characteristic "chronic hepatitis-liver cirrhosis-HCC" progression trilogy, patients w…

China800 participantsStarted 2025-05-16

Treatment: serum AKR1B10 levels

All recent trials (3 shown)

Not Yet RecruitingNot Applicable

NCT07344116

Hepatobiliary and Pancreatic Tumor Biobank

This study aims to establish a hepatobiliary and pancreatic tumor biobank at the Second Affiliated Hospital of Zhejiang University School of Medicine. The bioba…

Location not specified300 participantsStarted 2026-01-01

Treatment: No Interventions